The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research
Open Access
- 1 May 2009
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 82 (2) , A99-A109
- https://doi.org/10.1016/j.antiviral.2008.12.013
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Human Immunodeficiency Virus Type 1 Infection Increases the In Vivo Capacity of Peripheral Monocytes To Cross the Blood-Brain Barrier into the Brain and the In Vivo Sensitivity of the Blood-Brain Barrier to Disruption by LipopolysaccharideJournal of Virology, 2008
- Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System PharmacotherapyPharmacological Reviews, 2008
- Antiretroviral Therapy and Central Nervous System HIV Type 1 InfectionThe Journal of Infectious Diseases, 2008
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous SystemArchives of Neurology, 2008
- Nanomedicine in the diagnosis and therapy of neurodegenerative disordersProgress in Polymer Science, 2007
- Novel Delivery System Enhances Efficacy of Antiretroviral Therapy in Animal Model for HIV-1 EncephalitisJournal of Cerebral Blood Flow & Metabolism, 2007
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006
- Mechanisms of the Blood–Brain Barrier Disruption in HIV-1 InfectionCellular and Molecular Neurobiology, 2005
- Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral TherapyJournal of Virology, 2005
- Human immunodeficiency virus I-induced expression of P-glycoproteinBiochemical and Biophysical Research Communications, 1990